Companies House iXbrl


Registered number: 10788783

Bioinnovat Limited
Unaudited Financial Statements
for the period ended 31 May 2018

Statement of Financial Position

as at 31 May 2018

2018
 
££
Called up share capital not paid
  -  
Fixed assets
  -  
Current assets
4,575    
Prepayments and accrued income
-    
Creditors: amounts falling due within one year
( 4,545 )  
Net current assets (liabilities)
  30  
Total assets less current liabilities
  30  
Creditors: amounts falling due after more than one year
  -  
Provisions for liabilities
  -  
Accruals and deferred income
  -  
Net assets
  30  
   
Capital and reserves
  30  

10788783 2017-05-25 2018-05-31 10788783 2018-05-31 10788783 2017-05-25 10788783 uk-frs102:WithinOneYear 2018-05-31 10788783 uk-frs102:AfterOneYear 2018-05-31 10788783 uk-bus:AuditExempt-NoAccountantsReport 2017-05-25 2018-05-31 10788783 uk-bus:AbbreviatedAccounts 2017-05-25 2018-05-31 10788783 uk-bus:Director1 1 2017-05-25 2018-05-31 10788783 uk-bus:Director1 2017-05-25 2018-05-31 10788783 uk-bus:Director1 1 2017-05-25 10788783 uk-bus:Director1 1 2018-05-31 10788783 uk-bus:Micro-entities 2017-05-25 2018-05-31 10788783 uk-bus:PrivateLimitedCompanyLtd 2017-05-25 2018-05-31 iso4217:GBP 10788783 countries:EnglandWales 2017-05-25 2018-05-31 10788783 uk-bus:RegisteredOffice 2017-05-25 2018-05-31

Footnotes to the Statement of Financial Position

Sukrita Sethi

1. Arrangements not included in Statement of Financial Position

The company has not entered into any arrangements not shown on the Statement of Financial Position.

2. Average number of employees

The average number of employees in the period was 1.

3. Directors’ benefits: advances, credit and guarantees

Sukrita Sethi

Included in debtors is an amount payable to the company by one of its directors. The amount is an advance of £2,545 made to Sukrita Sethi, a director of the company, on 01/06/2017.

During the accounting period the maximum amount payable by Sukrita Sethi was £19,137

The following conditions are attached to the amount payable by Sukrita Sethi:

  • There is no interest due to be paid on any outstanding amount
  • No fixed date has been set for the amount to be repaid to the company.
Opening balance 25/05/2017 Additional advance Amount repaid Amount written off Amounts waived Interest payable Closing balance 31/05/2018
£ £ £ £ £ £ £
0   ( 25,491 )
( 25,491 )
22,946
22,946  
0 0 0 ( 2,545 )

4. Guarantees, contingencies and other financial commitments

There are no guarantees, contingencies or other commitments not included in the financial statements.

Statutory Statements

In accordance with section 414(3) of the Companies Act 2006, these accounts have been prepared in accordance with the FRS 105: The Financial Reporting Standard applicable to the Micro-entities Regime for periods commencing on or after 1 January 2016. These accounts have been prepared in accordance with the provisions applicable to companies subject to the small companies regime.

For the period ending 31/05/2018 the company was entitled to exemption from audit under section 477 of the Companies Act 2006 relating to small companies.

The members have not required the company to obtain an audit in accordance with section 476 of the Companies Act 2006.

The directors acknowledge their responsibilities for complying with the requirements of Companies Act 2006 with respect to accounting records and the preparation of accounts

Company information

a) The company is registered in England and Wales

b) Company registration number - 10788783

c) The company is a private company and is limited by shares

d) The companies registered office address is First Floor, Telecom House, 125-135 Preston Road, Brighton, East Sussex, BN1 6AF, United Kingdom



Approved by the board of directors and signed on behalf of the board,

Bioinnovat Limited
Director Sukrita Sethi
Date of approval: 25/02/2019
The company was trading for the entire period 2017-05-25 2018-05-31 2018-05-31 biopharmaceutical consulting 2019-02-25 2019-02-25